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ABSTRACT
Rheumatoid arthritis is a common inflammatory condition associated with joint
destruction and disability. T lymphocytes, monocytes, and synoviocytes present within
the inflamed joint all contribute to the inflammatory response by production of lipid
mediators (eicosanoids) and peptide mediators (cytokines).
Interleukin-l7 is a relatively recently described pro-inflammatory T cell derived
cytokine which has been shown to induce monocyte and synoviocyte cytokine
production. In comparison to other T cell cytokines, such as interferon-y, it is found in
abundant levels in rheumatoid synovial tissue and fluid. T cells have also been shown
to induce monocyte and synoviocyte cytokine production through direct cell-cell
contact. Through these mechanisms T cells may contribute to the perpetuation of
infl ammation in rheumatoid arthritis'
The eicosanoids, prostaglandin Ez and thromboxans Az, which are formed via the
cyclooxygenase pathway, also have a role in promoting inflammation. To date most
work has concentrated on monocyte eicosanoid production and the effects of monocyte
derived prostaglandin Ez on T cell functions. Furthermore, there has been a view that T
cells do not contain cyclooxygenase and are therefore unable to produce eicosanoids'
The recognition that cyclooxygenase exists in both a constitutive form
(cyclooxygenase-1) and an inducible form (cyclooxygenase-2) has renewed interest in
cyclooxygenase in all cell types.
The aim of this thesis was to examine cyclooxygenase isotypes in T cells and to
characterize eicosanoid production by each isotype. The ability of T cells to contribute
to the inflammatory response via up-regulation of cyclooxygenase-2 in other cell types
was also examined.
The data presented in this thesis indicate that T cells contain cyclooxygenase-1, which
is able to produce small amounts of eicosanoids. Extensive analysis revealed no
evidence for induction of cyclooxygenase-2 in T cells. Furthermore, activated T cells
up-regulate expression of cyclooxygenase-2 in both monocytes and synoviocytes.
Interleukin-l7 was found to be an important mediator of cyclooxygenase-2 up-
regulation both directly and through synergy with tumor necrosis factor-a and
interleukin-lB. The therapeutic effects of tumor necrosis factor-o or interleukin-lB
blockade may in part be mediated by inhibition of synergy with interleukin-l7.
Interleukin-17 should be considered as a therapeutic target in the management of
rheumatoid arthritis.
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